Non-Alcoholic, Fatty

Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+91-9650213330
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/non-alcoholic-fatty-liver-disease-market-to-observe-impressive-growth-by-2032-evaluates-delveinsight--key-companies---medicinova-eli-lilly-and-company-astrazeneca-madrigal-pharmaceuticals-biomarin-pharmaceutical-glaxosmithk-302040352.html

en | boerse | 67926821 |